372 related articles for article (PubMed ID: 27795938)
1. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.
Jayakumar S; Harrison SA; Loomba R
Curr Hepatol Rep; 2016 Jun; 15(2):86-95. PubMed ID: 27795938
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.
Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A
J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
Tsai E; Lee TP
Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
Zhou JH; Cai JJ; She ZG; Li HL
World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography.
Tada T; Nishimura T; Yoshida M; Iijima H
J Med Ultrason (2001); 2020 Oct; 47(4):511-520. PubMed ID: 33089412
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
Castera L; Friedrich-Rust M; Loomba R
Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of nonalcoholic steatohepatitis screening.
Zhang E; Wartelle-Bladou C; Lepanto L; Lachaine J; Cloutier G; Tang A
Eur Radiol; 2015 Nov; 25(11):3282-94. PubMed ID: 25994191
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease.
Mansoor S; Collyer E; Alkhouri N
Curr Gastroenterol Rep; 2015 Jun; 17(6):23. PubMed ID: 26031832
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Caussy C; Johansson L
Endocrinol Diabetes Metab; 2020 Oct; 3(4):e00134. PubMed ID: 33102797
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.
Alkhouri N; McCullough AJ
Gastroenterol Hepatol (N Y); 2012 Oct; 8(10):661-8. PubMed ID: 24683373
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
Papatheodoridi M; Cholongitas E
Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD.
Natarajan Y; Loomba R
J Clin Exp Hepatol; 2022; 12(1):174-179. PubMed ID: 35068797
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
16. Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.
Koplay M; Sivri M; Erdogan H; Nayman A
World J Hepatol; 2015 Apr; 7(5):769-76. PubMed ID: 25914777
[TBL] [Abstract][Full Text] [Related]
17. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
Han MA; Saouaf R; Ayoub W; Todo T; Mena E; Noureddin M
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):379-390. PubMed ID: 28277807
[TBL] [Abstract][Full Text] [Related]
19. Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
Ajmera V; Loomba R
Semin Liver Dis; 2018 Feb; 38(1):14-20. PubMed ID: 29471562
[TBL] [Abstract][Full Text] [Related]
20. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
